Showing posts with label pancreatic cancer symptoms. Show all posts
Showing posts with label pancreatic cancer symptoms. Show all posts
Saturday, January 11, 2014
Monday, June 14, 2010
Understanding The Stages of Pancreatic Cancer
Understanding The Stages of Pancreatic Cancer
Pancreatic Cancer, also known as exocrine cancer, is a disease where malignant (cancer) cells appear in the tissues of the pancreas.
Uncontrolled multiplication of cells in the pancreas leads to pancreatic cancer. Explanations as to how one develops pancreatic cancer remain unexplained. But, it is not contagious. Over 29,000 people in the United States are diagnosed with the pancreatic cancer every year. Pancreatic cancer is treatable when caught early; but vast majority of cases are not diagnosed until too late. Five-year survival rates show 40 percent survival if the cancers are surgically removed while they have not grown in size and spread to the lymph nodes. What is stage IV cancer of the pancreas survival rate?
General research show that patients diagnosed with stage IV pancreatic cancer survive within a median of 6.8 months to a year upon diagnosis.
Uncontrolled multiplication of cells in the pancreas leads to pancreatic cancer. Explanations as to how one develops pancreatic cancer remain unexplained. But, it is not contagious. Over 29,000 people in the United States are diagnosed with the pancreatic cancer every year. Pancreatic cancer is treatable when caught early; but vast majority of cases are not diagnosed until too late. Five-year survival rates show 40 percent survival if the cancers are surgically removed while they have not grown in size and spread to the lymph nodes. What is stage IV cancer of the pancreas survival rate?
General research show that patients diagnosed with stage IV pancreatic cancer survive within a median of 6.8 months to a year upon diagnosis.
Monday, May 24, 2010
Surgery The Only Hope For Pancreatic Cancer
90% of Pancreatic Cancer is unresectable at the time of diagnosis. Only about 10% has the chance of surgery and hence cure at the time of diagnosis.That makes Pancreatic Cancer as one of the most feared Cancer to get. Having said that,we hear many people including celebrities who have been cured of Pancreatic Cancer by surgery.This is because Pancreatic Cancer is quite common in the community who are living the modern/western lifestyle.
Surgery is the main hope for cure.Other modalities of treatment are at best "experimental" in nature.
Nonetheless,a chemotherapeutic agent Gemcitabine has very promising outcome to improve in the success of treating pancreatic cancer.
The best chance of treating Pancreatic Cancer is to detect/discover them early even before the classical symptoms of jaundice appears.Patients with vague abdominal or back pain not responding to the usual treatment of abdominal and back pain should undergo a CT abdomen with a tumour marker study of CA19-9.
in reference to: http://www.cancerjournals.net/part-1-pancreatic-cancer-and-the-latest-treatments-ask-dr-patrick-g-jackson/ (view on Google Sidewiki)
Surgery is the main hope for cure.Other modalities of treatment are at best "experimental" in nature.
Nonetheless,a chemotherapeutic agent Gemcitabine has very promising outcome to improve in the success of treating pancreatic cancer.
The best chance of treating Pancreatic Cancer is to detect/discover them early even before the classical symptoms of jaundice appears.Patients with vague abdominal or back pain not responding to the usual treatment of abdominal and back pain should undergo a CT abdomen with a tumour marker study of CA19-9.
in reference to: http://www.cancerjournals.net/part-1-pancreatic-cancer-and-the-latest-treatments-ask-dr-patrick-g-jackson/ (view on Google Sidewiki)
Thursday, May 20, 2010
Binge drinking linked to pancreatic cancer
A new research from UT Southwestern Medical Center suggests that heavy alcohol use and binge drinking can increase the risk of pancreatic cancer in men.
Researchers found that men who consumed alcohol increased their risk of pancreatic cancer by 1.5 to 6 times compared with those who didn't consume alcohol or who had less than one drink per month.
Also, men who engaged in binge drinking had a 3.5 times greater likelihood of developing pancreatic cancer.
"If this relationship continues to be confirmed, reducing heavy and binge drinking may be more important than we already know," said Dr. Samir Gupta, assistant professor of internal medicine at UT Southwestern and lead author of the study, which was conducted at the University of California, San Francisco.
source:http://timesofindia.indiatimes.com/Life/Health-Fitness/Health/Binge-drinking-linked-to-pancreatic-cancer/articleshow/5952739.cms
Researchers found that men who consumed alcohol increased their risk of pancreatic cancer by 1.5 to 6 times compared with those who didn't consume alcohol or who had less than one drink per month.
Also, men who engaged in binge drinking had a 3.5 times greater likelihood of developing pancreatic cancer.
"If this relationship continues to be confirmed, reducing heavy and binge drinking may be more important than we already know," said Dr. Samir Gupta, assistant professor of internal medicine at UT Southwestern and lead author of the study, which was conducted at the University of California, San Francisco.
source:http://timesofindia.indiatimes.com/Life/Health-Fitness/Health/Binge-drinking-linked-to-pancreatic-cancer/articleshow/5952739.cms
Saturday, May 15, 2010
In Patients With Pancreatic Disease, Quality-Of-Life Testing May Predict Malignancy And Survival
Quality-of-life measures used routinely to assess treatment outcomes for patients with pancreatic disease may be used to predict both malignancy and survival for those patients, according to a study by Henry Ford Hospital.
Researchers found that pre-treatment quality-of-life scores could predict malignancy in patients with pancreatic lesions and survival in those who are found to have malignancies.
"Our findings suggest that pretreatment quality-of-life scores may show which patients will have a poor survival and therefore could avoid aggressive, but futile, treatment," says Vic Velanovich, M.D., chief of General Surgery at Henry Ford Hospital and lead author of the study.
Source :http://www.medicalnewstoday.com/articles/187555.php
Researchers found that pre-treatment quality-of-life scores could predict malignancy in patients with pancreatic lesions and survival in those who are found to have malignancies.
"Our findings suggest that pretreatment quality-of-life scores may show which patients will have a poor survival and therefore could avoid aggressive, but futile, treatment," says Vic Velanovich, M.D., chief of General Surgery at Henry Ford Hospital and lead author of the study.
Source :http://www.medicalnewstoday.com/articles/187555.php
Wednesday, May 5, 2010
Ulcerative colitis in men linked to increased risk for pancreatic cancer | HemOncToday
Ulcerative colitis in men linked to increased risk for pancreatic cancer | HemOncToday
Patients with inflammatory bowel disease had six times the risk for developing pancreatic neoplasia, and men with ulcerative colitis had five times the risk for developing pancreatic neoplasia in a prospective study of more than 2,800 patients.
Because there is a known association between inflammatory bowel disease (IBD) and primary sclerosing cholangitis and cholangiocarcinoma within the bile ducts, as well as between primary sclerosing cholangitis and pancreatic cancer, researchers suspected that patients with IBD would be at greater risk for the development of pancreatic cancer.
To test their supposition, researchers prospectively examined 2,877 adults with IBD who were treated in the University of Utah Health System from January 1996 to December 2006. The IBD cohort was then matched to the Utah Cancer Registry and the Utah Population Database to determine the number of patients diagnosed with IBD and pancreatic cancer.
Friday, April 30, 2010
Push for progress on pancreatic cancer
Push for progress on pancreatic cancer
You won't see it on a billboard or targeted in a police blitz, but you're more likely to die of pancreatic cancer in Australia than from a road accident.
Pancreatic cancer claims five Australian lives every day as one of the nation's most lethal diseases and yet it has remained off the health radar - in part, because of the grim prognosis of sufferers and no significant development in treatment.
"Despite considerable research efforts into pancreatic cancer over the last decade, very little progress has been made in the treatment of this disease," says Professor David Goldstein, a medical oncologist and director of the Sydney-based GI CANCER Institute.
Posted using ShareThis
You won't see it on a billboard or targeted in a police blitz, but you're more likely to die of pancreatic cancer in Australia than from a road accident.
Pancreatic cancer claims five Australian lives every day as one of the nation's most lethal diseases and yet it has remained off the health radar - in part, because of the grim prognosis of sufferers and no significant development in treatment.
"Despite considerable research efforts into pancreatic cancer over the last decade, very little progress has been made in the treatment of this disease," says Professor David Goldstein, a medical oncologist and director of the Sydney-based GI CANCER Institute.
Posted using ShareThis
Sunday, April 25, 2010
What Are The Risk Factors For Pancreatic Cancer? | Health Tips
What Are The Risk Factors For Pancreatic Cancer? | Health Tips
Pancreatic cancer is currently the fifth most common form of cancer in the United States and is diagnosed in around 40,000 Americans each year. In most cases pancreatic cancer has an extremely poor survival outcome. Just 1 in 20 people diagnosed with pancreatic cancer will still be alive after five years.
The main reason pancreatic cancer has such a poor survival outcome is that the majority of cases are diagnosed when the cancer is at a very late stage. This is due to the non-specific symptoms associated with pancreatic cancer in its early stages. Early warning signs of pancreatic cancer include pain in the upper abdomen, jaundice, loss of appetite, and weight loss.
There are several risk factors that are known to affect an individuals probability of developing pancreatic cancer. While some of these cannot be changed, several can be influenced by sensible lifestyle and diet modifications.
Here are eleven of the more established risk factors for pancreatic cancer.
Posted using ShareThis
Pancreatic cancer is currently the fifth most common form of cancer in the United States and is diagnosed in around 40,000 Americans each year. In most cases pancreatic cancer has an extremely poor survival outcome. Just 1 in 20 people diagnosed with pancreatic cancer will still be alive after five years.
The main reason pancreatic cancer has such a poor survival outcome is that the majority of cases are diagnosed when the cancer is at a very late stage. This is due to the non-specific symptoms associated with pancreatic cancer in its early stages. Early warning signs of pancreatic cancer include pain in the upper abdomen, jaundice, loss of appetite, and weight loss.
There are several risk factors that are known to affect an individuals probability of developing pancreatic cancer. While some of these cannot be changed, several can be influenced by sensible lifestyle and diet modifications.
Here are eleven of the more established risk factors for pancreatic cancer.
Posted using ShareThis
Wednesday, April 21, 2010
Immunomedics Reports New Blood Test for Detecting Early Stage Pancreatic Cancer Correlates With Response to Clivatuzumab Tetraxetan Treatment - MarketWatch
Immunomedics Reports New Blood Test for Detecting Early Stage Pancreatic Cancer Correlates With Response to Clivatuzumab Tetraxetan Treatment - MarketWatch
Immunomedics, Inc. /quotes/comstock/15*!immu/quotes/nls/immu (IMMU 3.72, 0.00, 0.00%) , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that a new blood test using the Company's proprietary humanized antibody, clivatuzumab or PAM4, predicted a partial response in an initial set of patients treated with a combination of the antibody labeled with yttrium-90 (Y-90) and gemcitabine. Results were presented at the 101st Annual Meeting of the American Association for Cancer Research.
Posted using ShareThis
Immunomedics, Inc. /quotes/comstock/15*!immu/quotes/nls/immu (IMMU 3.72, 0.00, 0.00%) , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that a new blood test using the Company's proprietary humanized antibody, clivatuzumab or PAM4, predicted a partial response in an initial set of patients treated with a combination of the antibody labeled with yttrium-90 (Y-90) and gemcitabine. Results were presented at the 101st Annual Meeting of the American Association for Cancer Research.
Posted using ShareThis
Saturday, April 10, 2010
Studies Show Soda Linked to Pancreatic Cancer
Studies Show Soda Linked to Pancreatic Cancer
A new study has found a new negative thing related to sodas. Researchers at the University of Minnesota’s School of Public Health decided to cull through data from the Singapore Chinese Health Study, assessing whether sugar-sweetened soft drinks and juices had a noticeable effect in a different population. They concluded: yes on soft drinks, no on juices. In fact, consumption of two or more soft drinks a week was linked to an 87% increase in the risk of pancreatic cancer.
A new study has found a new negative thing related to sodas. Researchers at the University of Minnesota’s School of Public Health decided to cull through data from the Singapore Chinese Health Study, assessing whether sugar-sweetened soft drinks and juices had a noticeable effect in a different population. They concluded: yes on soft drinks, no on juices. In fact, consumption of two or more soft drinks a week was linked to an 87% increase in the risk of pancreatic cancer.
Subscribe to:
Posts (Atom)